The Europe Cat Vaccine Market is projected to witness market growth of 8.9% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Cat Vaccine Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $166 million by 2031. The UK market is exhibiting a CAGR of 7.9% during (2024 - 2031). Additionally, The France market is projected to experience a CAGR of 10.1% during (2024 - 2031).
Organizations like the American Veterinary Medical Association (AVMA) have been instrumental in promoting pet health awareness in the United States. The AVMA runs numerous campaigns highlighting the importance of vaccinations in preventing diseases such as rabies, feline leukemia virus (FeLV), and feline immunodeficiency virus (FIV). In Europe, similar initiatives are seen through the efforts of the Federation of Veterinarians of Europe (FVE). The FVE works closely with national veterinary associations to raise awareness about pet health and vaccinations.
For example, in the United Kingdom, the British Veterinary Association (BVA) collaborates with local veterinarians to run vaccination awareness campaigns. These campaigns include Pet Health Weeks, during which clinics offer discounted vaccination services and educational workshops for pet owners. Such initiatives have significantly increased public awareness about the importance of vaccinating pets and have increased vaccination rates.
In Germany, the rising demand for cat vaccines is largely attributed to the country's comprehensive pet health regulations and high pet ownership rates. The German Pet Trade & Industry Association (ZZF) reports about 15.7 million cats in German households. German regulations require vaccinations for cats, particularly against rabies, which is mandatory for cats traveling within the European Union. The Federal Ministry of Food and Agriculture (BMEL) supports vaccination programs and campaigns that promote responsible pet ownership and preventive healthcare. Additionally, German veterinary practices are well-integrated with national and EU-wide health initiatives, providing consistent and accessible vaccination services. Thus, the European cat vaccine market presents a promising picture.
The Germany market dominated the Europe Cat Vaccine Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $166 million by 2031. The UK market is exhibiting a CAGR of 7.9% during (2024 - 2031). Additionally, The France market is projected to experience a CAGR of 10.1% during (2024 - 2031).
Organizations like the American Veterinary Medical Association (AVMA) have been instrumental in promoting pet health awareness in the United States. The AVMA runs numerous campaigns highlighting the importance of vaccinations in preventing diseases such as rabies, feline leukemia virus (FeLV), and feline immunodeficiency virus (FIV). In Europe, similar initiatives are seen through the efforts of the Federation of Veterinarians of Europe (FVE). The FVE works closely with national veterinary associations to raise awareness about pet health and vaccinations.
For example, in the United Kingdom, the British Veterinary Association (BVA) collaborates with local veterinarians to run vaccination awareness campaigns. These campaigns include Pet Health Weeks, during which clinics offer discounted vaccination services and educational workshops for pet owners. Such initiatives have significantly increased public awareness about the importance of vaccinating pets and have increased vaccination rates.
In Germany, the rising demand for cat vaccines is largely attributed to the country's comprehensive pet health regulations and high pet ownership rates. The German Pet Trade & Industry Association (ZZF) reports about 15.7 million cats in German households. German regulations require vaccinations for cats, particularly against rabies, which is mandatory for cats traveling within the European Union. The Federal Ministry of Food and Agriculture (BMEL) supports vaccination programs and campaigns that promote responsible pet ownership and preventive healthcare. Additionally, German veterinary practices are well-integrated with national and EU-wide health initiatives, providing consistent and accessible vaccination services. Thus, the European cat vaccine market presents a promising picture.
List of Key Companies Profiled
- Zoetis, Inc.
- Elanco Animal Health, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation (Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, a.s.
Market Report Segmentation
By Component- Combined Vaccines
- Mono Vaccines
- Injectables
- Intranasal
- Oral
- 1 Year
- 3 Year
- Others
- Feline Respiratory Diseases
- Feline Rabies
- Feline Panleukopenia (Feline Distemper)
- Feline Leukemia
- Others
- Modified/Attenuated Live
- Inactivated (Killed)
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Europe Cat Vaccine Market by Component
Chapter 6. Europe Cat Vaccine Market by Route of Administration
Chapter 7. Europe Cat Vaccine Market by Duration of Immunity
Chapter 8. Europe Cat Vaccine Market by Disease Type
Chapter 9. Europe Cat Vaccine Market by Type
Chapter 10. Europe Cat Vaccine Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Zoetis, Inc.
- Elanco Animal Health, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation (Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, a.s.
Methodology
LOADING...
